These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37195568)

  • 41. Modeled prenatal exposure to per- and polyfluoroalkyl substances in association with child autism spectrum disorder: A case-control study.
    Shin HM; Bennett DH; Calafat AM; Tancredi D; Hertz-Picciotto I
    Environ Res; 2020 Jul; 186():109514. PubMed ID: 32353786
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Folate concentrations and serum perfluoroalkyl and polyfluoroalkyl substance concentrations in adolescents and adults in the USA (National Health and Nutrition Examination Study 2003-16): an observational study.
    Zhang Y; Mustieles V; Wang YX; Sun Y; Agudelo J; Bibi Z; Torres N; Oulhote Y; Slitt A; Messerlian C
    Lancet Planet Health; 2023 Jun; 7(6):e449-e458. PubMed ID: 37286242
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum per- and polyfluoroalkyl substances and abnormal lipid metabolism: A nationally representative cross-sectional study.
    Wu B; Pan Y; Li Z; Wang J; Ji S; Zhao F; Chang X; Qu Y; Zhu Y; Xie L; Li Y; Zhang Z; Song H; Hu X; Qiu Y; Zheng X; Zhang W; Yang Y; Gu H; Li F; Cai J; Zhu Y; Cao Z; S Ji J; Lv Y; Dai J; Shi X
    Environ Int; 2023 Feb; 172():107779. PubMed ID: 36746113
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dietary characteristics associated with plasma concentrations of per- and polyfluoroalkyl substances among adults with pre-diabetes: Cross-sectional results from the Diabetes Prevention Program Trial.
    Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Fleisch AF; Calafat AM; Sanchez-Guerra M; Osorio-Yáñez C; Webster TF; Horton ES; Oken E
    Environ Int; 2020 Apr; 137():105217. PubMed ID: 32086073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study.
    Starling AP; Engel SM; Whitworth KW; Richardson DB; Stuebe AM; Daniels JL; Haug LS; Eggesbø M; Becher G; Sabaredzovic A; Thomsen C; Wilson RE; Travlos GS; Hoppin JA; Baird DD; Longnecker MP
    Environ Int; 2014 Jan; 62():104-12. PubMed ID: 24189199
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Temporal trends and predictors of perfluoroalkyl substances serum levels in Swedish pregnant women in the SELMA study.
    Shu H; Lindh CH; Wikström S; Bornehag CG
    PLoS One; 2018; 13(12):e0209255. PubMed ID: 30596681
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum per- and polyfluoroalkyl substance concentrations in four municipal US fire departments.
    Burgess JL; Fisher JM; Nematollahi A; Jung AM; Calkins MM; Graber JM; Grant CC; Beitel SC; Littau SR; Gulotta JJ; Wallentine DD; Hughes RJ; Popp C; Calafat AM; Botelho JC; Coleman AD; Schaefer-Solle N; Louzado-Feliciano P; Oduwole SO; Caban-Martinez AJ
    Am J Ind Med; 2023 May; 66(5):411-423. PubMed ID: 35864570
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prenatal plasma concentrations of Perfluoroalkyl and polyfluoroalkyl substances and neuropsychological development in children at four years of age.
    Niu J; Liang H; Tian Y; Yuan W; Xiao H; Hu H; Sun X; Song X; Wen S; Yang L; Ren Y; Miao M
    Environ Health; 2019 Jun; 18(1):53. PubMed ID: 31196101
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The association between blood PFAS concentrations and clinical biochemical measures of organ function and metabolism in participants of the Canadian Health Measures Survey (CHMS).
    Cakmak S; Lukina A; Karthikeyan S; Atlas E; Dales R
    Sci Total Environ; 2022 Jun; 827():153900. PubMed ID: 35218824
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biomonitoring of perfluoroalkyl and polyfluoroalkyl substances (PFAS) from the Survey of the Health of Wisconsin (SHOW) 2014-2016 and comparison with the National Health and Nutrition Examination Survey (NHANES).
    Schultz A; Stanton N; Pomazal R; Lange M; Irving R; Meiman J; Shelton B; Malecki KC
    medRxiv; 2023 Feb; ():. PubMed ID: 36865127
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum concentrations of perfluoroalkyl substances and their association with osteoporosis in a population in Jeddah, Saudi Arabia.
    Banjabi AA; Li AJ; Kumosani TA; Yousef JM; Kannan K
    Environ Res; 2020 Aug; 187():109676. PubMed ID: 32485360
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PPARα/ACOX1 as a novel target for hepatic lipid metabolism disorders induced by per- and polyfluoroalkyl substances: An integrated approach.
    Yang W; Ling X; He S; Cui H; Yang Z; An H; Wang L; Zou P; Chen Q; Liu J; Ao L; Cao J
    Environ Int; 2023 Aug; 178():108138. PubMed ID: 37572494
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isomers of per- and polyfluoroalkyl substances and uric acid in adults: Isomers of C8 Health Project in China.
    Zeng XW; Lodge CJ; Dharmage SC; Bloom MS; Yu Y; Yang M; Chu C; Li QQ; Hu LW; Liu KK; Yang BY; Dong GH
    Environ Int; 2019 Dec; 133(Pt A):105160. PubMed ID: 31518937
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mediation effects of DNA methylation and hydroxymethylation on birth outcomes after prenatal per- and polyfluoroalkyl substances (PFAS) exposure in the Michigan mother-infant Pairs cohort.
    Petroff RL; Cavalcante RG; Langen ES; Dolinoy DC; Padmanabhan V; Goodrich JM
    Clin Epigenetics; 2023 Mar; 15(1):49. PubMed ID: 36964604
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Perfluoroalkyl substance exposure is associated with asthma and innate immune cell count in US adolescents stratified by sex.
    Pan Z; Guo Y; Zhou Q; Wang Q; Pan S; Xu S; Li L
    Environ Sci Pollut Res Int; 2023 Apr; 30(18):52535-52548. PubMed ID: 36840869
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Perfluoroalkyl substances and sex hormones in postmenopausal women: NHANES 2013-2016.
    Wang Y; Aimuzi R; Nian M; Zhang Y; Luo K; Zhang J
    Environ Int; 2021 Apr; 149():106408. PubMed ID: 33548847
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Temporal trends of concentrations of per- and polyfluoroalkyl substances among adults with overweight and obesity in the United States: Results from the Diabetes Prevention Program and NHANES.
    Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Calafat AM; Webster TF; Horton ES; Oken E
    Environ Int; 2021 Dec; 157():106789. PubMed ID: 34333293
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictors of Per- and Polyfluoroalkyl Substance (PFAS) Plasma Concentrations in 6-10 Year Old American Children.
    Harris MH; Rifas-Shiman SL; Calafat AM; Ye X; Mora AM; Webster TF; Oken E; Sagiv SK
    Environ Sci Technol; 2017 May; 51(9):5193-5204. PubMed ID: 28325044
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Perfluoroalkyl substances exposure and hearing impairment in US adults.
    Ding N; Park SK
    Environ Res; 2020 Aug; 187():109686. PubMed ID: 32474307
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Longitudinal trends in perfluoroalkyl and polyfluoroalkyl substances among multiethnic midlife women from 1999 to 2011: The Study of Women's Health Across the Nation.
    Ding N; Harlow SD; Batterman S; Mukherjee B; Park SK
    Environ Int; 2020 Feb; 135():105381. PubMed ID: 31841808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.